Cumberland Pharmaceuticals Inc
CPIX· Nasdaq
CPIXCumberland Pharmaceuticals Inc
Filed Mar 12, 2013 · 10-K · 71 days after period end · 0001445305-13-000573
| Metric | Q4 2012 | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|---|
| Revenue | $13.70M | $13.03M | — |
| Net Income | $1.81M | $911.67K | — |
| EPS Diluted | $0.09 | $0.04 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cumberland Pharmaceuticals Inc · CIK 1087294 · Engraved from SEC EDGAR
ended Dec 31, 2012 · filed Mar 12, 2013 · 71 d after period end
